Abstract
The benefits of multi-dose rituximab cycles in patients with refractory anti-muscle-specific kinase antibody myasthenia gravis (MuSK+MG) are well repo......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
